WOCKPHARMA.BOWOCKPHARMA.BOBSE
Loading
EV to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+73.0%
5Y CAGR+34.0%
Studio
Year-over-Year Change

Enterprise value to sales ratio

3Y CAGR
+73.0%/yr
vs -12.7%/yr prior
5Y CAGR
+34.0%/yr
Recent acceleration
Acceleration
+85.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
3 yr
Consecutive growthElevated
PeriodValueYoY Change
20258.03+116.6%
20243.71+128.4%
20231.62+4.7%
20221.55-40.3%
20212.59+39.9%
20201.85-17.5%
20192.25-15.9%
20182.67+0.9%
20172.65+0.6%
20162.63-